| Date & Time | 1 October 2025 at 12.00-13.00 CEST |
|---|---|
| Location | Online |
Please save the date for Bridging Nordic ATMP, the new season of ATMP Webinar Series hosted by the Nordic EATRIS Nodes (Sweden, Norway and Finland). This season of the series will take place online 12.00-13.00 CEST, once a month with a lecture by an expert in the Advanced Therapy Medicinal Products (ATMPs) field. The next edition will feature the following speaker:
Prof. Joel Clinton Glover, Director of Norwegian Core Facility for Human Pluripotent Stem Cells at the University of Oslo and Oslo University Hospital.
Talk title: ” Establishing NIBCA – the Norwegian iPSC Biobank for Clinical Applications – GMP and pre-GMP activities in Oslo”
Joel Clinton Glover is currently leading the establishment of NIBCA – the Norwegian iPSC Biobank for Clinical Applications at Oslo University Hospital. His work focuses on developing the infrastructure and standards for GMP and pre-GMP production of iPSCs, supporting advanced therapy development across Norway. With deep expertise in stem cell research, translational neuroscience, and cell-based models of neurological disease, Glover brings a unique perspective on how to enable the clinical-grade application of iPSC technologies.
Register for the webinar here.
Remember to save the dates and look out for updates on each webinar before the start of the event.
The next webinars will take place on:
- 5 November 2025
- 3 December 2025
The previous events took place on:
- 5 February 2025 – Magnus Essand, Professor of Gene Therapy, Uppsala University, Chief Scientific Officer and co-founder, Elicera Therapeutics
- 12 March 2025 – David Morrow, EATRIS Senior Scientific Programme Manager
- 2 April 2025 – Seppo Ylä-Herttuala, Professor at the University of Eastern Finland
- 7 May 2025 – Kamal Mustafa, Professor at the University of Bergen
- 4 June 2025 – Marie Gårdmark, Co-founder of RegSmart Life Science AB and Anna Pasetto, Director of the Centre for Advanced Cell Therapy (ACT) at Oslo University Hospital
- 3 September 2025 – Janet Hoogstraate, PhD, Chief Executive Officer at NorthX Biologics
